Related Experiment Video
Updated: Apr 2, 2026
07:53
Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
7.9K
Integrating Multi-Dimensional Data to Advance Global Health Equity in Oncology
Yuan Liu1,2,3, Eytan Ruppin4,5, Leng Han1,2,3
1Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana.
Cancer Discovery
|April 1, 2026
Summary
Precision oncology advances cancer care but faces disparities due to resource and representation gaps. Integrating diverse data sources can identify drivers of inequities and improve global cancer treatment decisions.
Area of Science:
- Oncology
- Genomics
- Health Equity
Background:
- Precision oncology has revolutionized cancer treatment.
- Significant disparities exist in accessing and benefiting from precision oncology.
- Gaps in resources and representation limit equitable care.
Purpose of the Study:
- To address the uneven distribution of precision oncology benefits.
- To identify biological and extrinsic drivers of cancer inequities.
- To advance treatment decisions for diverse global populations.
Main Methods:
- Integrating multiomics data.
- Incorporating clinical trial evidence.
- Utilizing real-world data.
Main Results:
- Identification of key biological drivers of cancer inequities.
- Uncovering extrinsic factors contributing to disparities in cancer care.
- Demonstrated potential for improved treatment strategies.
Conclusions:
- Multiomics, clinical, and real-world data integration is crucial.
- Addressing resource and representation gaps is essential for equity.
- This approach can enhance precision oncology outcomes globally.
Related Concept Videos
01:21Dimensions of Health and Illness
12.0K
The factors influencing the health-illness continuum can be internal or external and may or may not be under conscious control. They are related to the following eight human dimensions, and each dimension is interrelated to one other.
12.0K
01:21Cancer Survival Analysis
832
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
832
02:56Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:50Combination Therapies and Personalized Medicine
1.8K
1.8K
02:49Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K